How Placebo Effects Work to Change Our Biology & Psychology

KEYPOINTS

• 01

  Placebo, nocebo and belief effects are distinct but share one engine: expectation

  A placebo is an inert pill or behavioral treatment that improves symptoms or performance; a nocebo is an inert treatment that makes them worse. Belief effects occur when specific information you learn changes what you expect, and that expectation produces the outcome. Huberman stresses that none of these are 'just in your head': they change heart rate, blood pressure, hormone output and neuromodulators like dopamine and adrenaline.

• 02

  The prefrontal cortex is the hub that turns expectation into physiology

  The prefrontal cortex evaluates context, memories and goals, and largely works by activating or suppressing deeper circuits. Some of its subregions have dedicated 'labeled line' connections to the hypothalamus and brainstem, which control ancient functions such as stress responses, body temperature and breathing. That anatomy is why what you are told about a pill can reach systems you cannot consciously command.

• 03

  A sugar pill can cause measurable dopamine release in Parkinson's patients

  In placebo-controlled Parkinson's trials, people told an inert pill would raise dopamine showed symptom improvements and PET imaging evidence of more dopamine release, seen as reduced binding of the tracer raclopride at dopamine receptors. Two caveats keep this from replacing real drugs: placebo-driven dopamine increases are generally smaller than those from L-DOPA, apomorphine or bromocriptine, and the effect shrinks when people realize they are taking a placebo.

• 04

  Placebo responses can be conditioned, not just suggested

  Pairing a context with a real physiological effect teaches the body to reproduce that effect. Smells from a bakery or pizza shop raise insulin because of past eating experiences, and in experiments a bell or buzzer paired with food later triggered an insulin rise on its own. Huberman frames this as the brain lumping environmental cues together and making simplified predictions below awareness.

• 05

  Packaging, color and invasiveness change the size of a placebo effect

  Brand-name placebos (even invented names with a trademark symbol) outperform generic ones, and pills pushed out of foil or taken from labeled bottles beat pills set on a tray. Capsules beat tablets, injections beat capsules, and inert medical machines that hum and click produce the largest effects. The brain has learned to equate complexity and invasiveness with bigger outcomes.

• 06

  Placebo effects are powerful but specific and limited

  In cancer care, placebos can reduce pain, nausea and other side effects of chemotherapy or radiation, improving well-being, but they do not shrink or eliminate tumors. Huberman separates three categories: proven behavioral supports such as sleep, stress reduction and social support, which act by lowering inflammation and stress hormones; real treatments such as drugs, radiation and immunotherapy; and genuine expectation effects, which have limits.

• 07

  Expectation scales with the dose you think you received

  In the study 'Nicotine-related beliefs induce dose-dependent responses in the human brain,' everyone vaped the same real dose of nicotine but was told it was low, medium or high. Cognitive task performance and activity in a nicotine-responsive brain region both rose stepwise with the believed dose. Huberman calls it one of his favorite papers because it ties belief, brain activity and performance together.

• 08

  There is a mapped circuit from thought to the stress response

  A rat study titled 'A central master driver of psychosocial stress responses' traced a prefrontal region (the dorsal peduncular cortex and dorsal tenia tecta) to the dorsomedial hypothalamus, then to the rostral medullary raphe in the brainstem, and out to the body. This pathway drives blood pressure, peripheral vasoconstriction, body temperature and brown-fat thermogenesis during social stress. Huberman notes analogous circuitry exists in humans. By contrast, no known pathway lets belief grow one quadriceps more than the other.

• 09

  People differ in how strongly they respond to placebos, partly through genes

  The first formal placebo study found roughly 30% of participants showed a robust effect and 70% a weaker one, and that spread has recurred across studies. Variation in the COMT gene, which encodes catechol-O-methyltransferase, an enzyme that regulates dopamine, epinephrine and norepinephrine, correlates with the strength of some placebo responses. That fits the fact that many placebo effects involve catecholamine systems.